Evidence map›Paper›PMID 41123713›Full record

ArticleJournal of materials science. Materials in medicine2025

Enhancing Anticancer Effects: Targeted Doxorubicin Delivery Using UiO-66-NH

Adeleh Saffar, Tahereh Rohani Bastami, Amir Ebrahimi, Sonia Iranpour, Mohammad Hasan Mollaei, Ahmad Reza Bahrami, Maryam M Matin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Adeleh SaffarDepartment of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
Tahereh Rohani BastamiDepartment of Chemical Engineering, Faculty of Advanced Technologies, Quchan University of Technology, Quchan, 94771-77870, Iran.
Amir EbrahimiDepartment of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
Sonia IranpourDepartment of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
Mohammad Hasan MollaeiDepartment of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
Ahmad Reza BahramiDepartment of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
Maryam M MatinDepartment of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran. matin@um.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of targeted drug delivery systems to accumulate medications in cancer cells, along with the simultaneous application of multiple drugs, can facilitate the administration of optimal doses, leading to more efficient treatment as well as reduced side effects. We fabricated zirconium-based UiO-66-NH

Indexed as

AutophagyColorectal NeoplasmsDoxorubicinFolic AcidHydroxychloroquineMetal-Organic FrameworksAntineoplastic AgentsDrug CarriersDrug Delivery SystemsDrug LiberationHEK293 CellsHT29 CellsHumansNanoparticlesPhthalic AcidsZirconiumAntineoplastic AgentsDoxorubicinDrug CarriersFolic AcidHydroxychloroquineMetal-Organic FrameworksPhthalic AcidsUiO-66Zirconium

Identifiers

PMID41123713
PMCPMC12546378

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.